Since either GSKJ4 or A-485 treatment decreased c-Myc levels in T-ALL cells (Figures 5B,D), we reasoned that the axis between Notch signaling and c-Myc could be a critical target of these drugs and that c-Myc inhibition might be required for their biological effects. Here, MYC is linked to acute lymphoblastic leukemia.